Potentiation of NMDA receptor function by the serine protease thrombin

Journal of Neuroscience

Volumn 20, Issue 12, 2000, Pages 4582-4595

  Gingrich, Melissa B ^a   Junge, Candice E ^a   Lyuboslavsky, Polina ^a   Traynelis, Stephen F ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 5025 Rollins Research Center ^*  (United States)

Author keywords

Hippocampal neurons; NMDA receptor; PAR1; Protease receptor; Serine protease; Thrombin

Indexed keywords

DNA; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLASMA PROTEIN; PROTEIN KINASE INHIBITOR; PROTEINASE ACTIVATED RECEPTOR 1; SERINE PROTEINASE; THROMBIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; HIPPOCAMPUS; MOUSE; NEWBORN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT;

EID: 0034660448     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-12-04582.2000     Document Type: Article

References (113)

1. Andrew RD, MacVicar BA (1994) Imaging cell volume changes and neuronal excitation in the hippocampal slice. Neuroscience 62:371-383.
2. Aniksztejn L, Bregestovski P, Ben-Ari Y (1991) Selective activation of quisqualate metabotropic receptor potentiates NMDA hut not AMPA responses. Eur J Pharmacol 205:327-328.
3. Aniksztejn L, Otani S, Ben-Ari Y (1992) Quisqualate metabotropic receptors modulate NMDA currents and facilitate induction of long term potentiation through protein kinase C. Eur J Neurosci 4:500-505.
4. Annegers JF, Hauser WA, Coan SP, Rocca WA (1998) A population-based study of seizures after traumatic brain injuries. N Engl J Med 338:20-24.
5. Arand AG, Sawaya R (1986) Intraoperative chemical hemostasis in neurosurgery. Neurosurgery 18:223-233.
6. Arboix A, Garcia-Eroles L, Massons JB, Oliveres M, Comes E (1997) Predictive factors of early seizures after acute cerebrovascular disease. Stroke 28:1590-1594.
7. Baird DH, Trenkner E, Mason CA (1996) Arrest of afferent axon extension by target neurons in vitro is regulated by the NMDA receptor. J Neurosci 16:2642-2648.
8. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21:813-825.
9. Barzo P, Marmarou A, Fatouros P, Corwin F, Dunbar JG (1997) Acute blood-brain barrier changes in experimental closed head injury as measured by MRI and Gd-DTPA. Acta Neurochir Suppl (Wien) 70:243-246.
10. Q-protein α-subunit. Nature 389:296-299.
11. Berger AR, Lipton RB, Lesser ML, Lantos G, Portenoy RK (1988) Early seizures following intracerebral hemorrhage: implication for therapy. Neurology 38:1363-1365.
12. Blank T, Zwart R, Nijholt I, Spiess J (1996) Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents hy a protein kinase C-dependent mechanism. J Neurochem Res 45:153-160.
13. Bradford HF (1995) Glutamate, GABA, and epilepsy. Prog Neurobiol 47:477-511.
14. Butler MA, Traynelis SF (1996) Native and recombinant NMDA receptors are cleaved by the serine protease thrombin. Soc Neurosci Abstr 22:1761.
15. Cavanaugh KP, Gurwitz D, Cunningham DD, Bradshaw RA (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem 54:1735-1743.
16. Chen C, Okayama H (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
17. Chen L, Huang L-YM (1991) Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron 7:319-326.
18. 2+ block of NMDA receptor channels as a mechanism of modulation. Nature 356:521-523.
19. Chen Z-L, Yoshida S, Kato K, Momota Y, Suzuki J, Tanaka T, Ito J, Nishino H, Aimoto S, Kiyama H, Shiosaka S (1995) Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus. J Neurosci 15:5088-5097.
20. Connolly AJ, Ishihara H, Kahn ML, Farese RV, Coughlin SR (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516-519.
21. Correale J, Rabinowicz AL, Heck CN, Smith TD, Loskota WJ, DeGiorgio CM (1998) Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood brain barrier. Neurology 50:1388-1391.
22. Debeir T, Benavides J, Vige X (1998) Involvement of protease activated receptor-1 in the in vitro development of mesencephalic dopaminergic neurons. Neuroscience 82:739-752.
23. Dery O, Corver CU, Steinhoff M, Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274:C1429-C1452.
24. Dihanich M. Kaser M, Reinhard E, Cunningham DD, Monard D (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6:575-581.
25. Dirnagl U, Iadecola C, Moskowitz MA (1999) Pathobiology of ischacmic stroke: an integrated view. Trends Neurosci 22:391-397.
26. Donovan FM, Pike CJ, Cotman CW, Cunningham DD (1997) Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316-5326.
27. Du C, Hu R, Hsu CY, Choi DW (1996) Dextrorphan reduces infarct volume, vascular injury, and brain edema after ischemic brain injury. J Neurotrauma 13:215-222.
28. Durand GM, Bennett MV, Zukin RS (1993) Splice variants of the N-methyl-D-aspartate receptor NR1 identify domains involved in regulation by polyamines and protein kinase C. Proc Natl Acad Sci USA 90:6731-6735.
29. Faught E, Peters D, Bartolucci A, Moore L, Miller PC (1989) Seizures after primary intracerebral hemorrhage. Neurology 39:1089-1093.
30. Gerszten RE, Chen J, Ishii M, Ishii K, Wang L, Nanevicz T, Turck CW, Vu T-KH, Coughlin SR (1994) Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface. Nature 368:648-651.
31. ++ dependent. Soc Neurosci Abstr 24:1271.
32. 2+ block of the NMDA receptor. Soc Neurosci Abstr 23:947.
33. Gingrich MB, Rouse ST, Marino MJ, Conn PJ, Traynelis SF (1998) Potentiation of neuronal and recombinant NMDA receptors by activation of the thrombin receptor PARI in Xenopus oocytcs and rat hippocampal slices. J Physiol (Lond) 507:26P.
34. Grabham P, Cunningham DD (1995) Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J Neurochem 64:583-591.
35. Grand RJ, Turncll AS, Grabham P (1996) Cellular consequences of thrombin-receptor activation. Biochem J 313:353-368.
36. Grant ER, Bacskai BJ, Anegawa NJ, Pleasure DE, Lynch DR (1998) Opposing contributions of NR1 and NR2 to protein kinase C modulation of NMDA receptors. J Neurochem 71:1471-1481.
37. Gschwend TP, Krueger SR, Kozlov SV, Wolfer DP, Sonderegger P (1997) Neurotrypsin, a novel multidomain serine protease expressed in the central nervous system. Mol Cell Neurosci 9:207-219.
38. Gurwitz D, Cunningham DD (1988) Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc Natl Acad Sci USA 85:3440-3444.
39. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E (1995) Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European cooperative acute stroke study (ECASS). JAMA 274:1017-1025.
40. Hall KE, Browning MD, Dudek EM, MacDonald RL (1995) Enhancement of high threshold calcium currents in rat primary afferent neurons by constitutively active protein kinase C. J Neurosci 15:6069-6076.
41. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M, Lawrence DA (1997) Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons: implications for the regulation of motor learning and neuronal survival. J Biol Chem 272:33062-33067.
42. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74.
43. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zhent YW, Timmons C, Tram T, Coughlin SR (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386:502-506.
44. Junge C, Mannaioni G, Gingrich MB, Traynelis SF (1999) Plasmin and thrombin regulation of NMDA receptor function. Soc Neurosci Abstr 25:1979.
45. Kelso SR, Nelson TE, Leonard JP (1992) Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J Physiol (Lond) 449:705-718.
46. Kim Y-H, Park J-H, Hong SH, Koh J-Y (1999) Nonproteolytic neuro-protection by human recombinant tissue plasminogcn activator. Science 284:647-650.
47. Komuro H, Rakic P (1993) Modulation of neuronal migration by NMDA receptors. Science 260:95-97.
48. Krueger SR, Ghisu G-P, Cinelli P, Gschwend TP, Osterwalder T, Wolfer DP, Sonderegger P (1997) Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in developing and adult nervous system of the mouse. J Neurosci 17:8984-8996.
49. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M (1992) Molecular diversity of the NMDA receptor channel. Nature 358:36-41.
50. Lancman ME, Golimstok A, Norscini J, Granillo R (1993) Risk factors for developing seizures after a stroke. Epilepsia 34:141-143.
51. Lau L-F, Huganir RL (1995) Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits. J Biol Chem 270:20036-20041.
52. Laursen H, Hansen AJ, Sheardown M (1993) Cerebrovascular permeability and brain edema after photochemical infarcts in the rat. Acta Neuropathol (Berl) 86:378-385.
53. Lee J-M, Zipfel GJ, Choi DW (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399[Suppl]:A7-A14.
54. Lee KR, Colon GP, Betz AL, Keep RF, Kim S, Hoff JT (1996) Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 84:91-96.
55. Lee KR, Drury I, Vitarbo E, Hoff JT (1997) Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg 87:73-78.
56. Lee S-T, Lui T-N (1992) Early seizures after mild closed head injury. J Neurosurg 76:435-439.
57. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ (1998) Protein kinase C isotypes controlled by phosphoinositide 3-kinase through protein kinase PDK1. Science 281:2042-2045.
58. Leonard AS, Hell JW (1997) Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J Biol Chem 272:12107-12115.
59. Liu Y, Fields RD, Festoff BW, Nelson PG (1994) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc Natl Acad Sci USA 91:10300-10304.
60. Logan SM, Rivera FE, Leonard JP (1999) Protein kinase C modulation of recombinant NMDA receptor currents: roles for the C-terminal C1 exon and calcium ions. J Neurosci 19:974-986.
61. Luthi A, van der Putten H, Botteri FM, Mansuy IM, Meins M, Frey U, Sansig G, Portet C, Schmutz M, Schroder M, Nitsch C, Laurent J-P, Monard D (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J Neurosci 17:4688-4699.
62. Majerus PW, Broze GJ, Miletich JP, Tollefsen DM (1996) Anticoagulant, thrombolytic, and antiplatelet drugs. In: Goodman & Gilman's the pharmacological basis of therapeutics, Ed 9 (Hardman JG, Limbird LE, eds), p 1351. New York: McGraw-Hill.
63. Marais R, Light Y, Mason C, Paterson H, Olson MF, Marshall CJ (1998) Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280:109-112.
64. Marino MJ, Rouse ST, Levcy AI, Potter LT, Conn PJ (1998) Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc Natl Acad Sci USA 95:11465-11470.
65. Markram H, Segal M (1990) Long-lasting facilitation of excitatory postsynaptic potentials in the rat hippocampus by acetylcholine. J Physiol (Lond) 427:381-393.
66. Matsuda S, Mikawa S, Hirai H (1999) Phosphorylation of serine-880 in GluR2 by protein kinase C prevents its C terminus from binding with glutamate receptor interacting protein. J Neurochem 73:1765-1768.
67. McBain CJ, Traynelis SF, Dingledine R (1990) Regional variation of extracellular space in hippocampus. Science 249:674-677.
68. Miledi R (1982) A calcium-dependent transient outward current in Xenopus laevis oocytes. Proc R Soc Lond B Biol Sci 215:491-497.
69. Miledi R, Parker I (1984) Chloride current induced by injection of calcium into Xenopus oocytes. J Physiol (Lond) 357:173-183.
70. Mizutani A, Tanaka T, Saito H, Matsuki N (1997) Postsynaptic blockade of inhibitory postsynaptic currents by plasmin in CA1 pyramidal cells of rat hippocampal slices. Brain Res 761:93-96.
71. Mori H, Yamakura T, Masaki H, Mishina W (1993) Involvement of the carboxy-terminal region in modulation by TPA of the NMDA receptor channel. NeuroReport 4:519-522.
72. Motohashi O, Suzuki M, Shida N, Umezawa K, Sugai K, Yoshimoto T (1997) Hirudin suppresses the invasion of inflammatory cells and the appearance of vimentin-positive astrocytes in the rat cerebral ablation model. J Neurotrauma 14:747-754.
73. Nagy Z, Kolev K, Csonka E, Vastag M, Machovich R (1998) Perturbation of the integrity of the blood brain barrier by fibrinolytic enzymes. Blood Coagul Fibrinolysis 9:471-478.
74. Nakajima K, Tsuzaki N, Nagata K, Takemoto N, Kohsaka S (1992) Production and secretion of plasminogen in cultured rat brain microglia. FEBS Lett 308:179-182.
75. Niclou SP, Suidan HS, Pavlik A, Vejsada R, Monard D (1998) Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur J Neurosci 10:1590-1607.
76. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 10:167-179.
77. Obrenovitch TP, Urenjak J (1997) Is high extracellular glutamate the key to excitotoxicity in traumatic brain injury. J Neurotrauma 14:677-698.
78. Paoletti P, Ascher P, Neyton J (1997) High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 17:5711-5725.
79. Pindon A, Hantai D, Jandrot-Perrus M, Festoff BW (1997) Novel expression and localization of active thrombomodulin on the surface of mouse brain astrocytes. Glia 19:259-268.
80. Sah P, Hestrin S, Nicoll RA (1989) Tonic activation of NMDA receptors by ambient glutamate enhances excitability of neurons. Science 246:815-818.
81. Scarisbrick IA, Towner MD, Isackson PJ (1597) Nervous system-specific expression of a novel serine protease regulation in the adult rat spinal cord by excitotoxic injury. J Neurosci 17:8156-8168.
82. Scheetz AJ, Constantine-Paton M (1994) Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J 8:745-752.
83. Seegers WH (1962) Prothrombin. Cambridge, MA: Harvard UP.
84. Shimizu C, Yoshida S, Shibata M, Kato K, Momota Y, Matsumoto K, Shiosaka T, Midorikawa R, Kamachi T, Kawabe A, Shiosaka S (1998) Characterization of recombinant and brain neuropsin, a plasticity-related serine protease. J Biol Chem 273:11189-11196.
85. Siegel SJ, Brose N, Janssen WG, Gasic GP, Jahn R, Heinemann SF, Morrison JH (1994) Regional, cellular, and ultrastructural distribution of N-methyl-D-aspartate receptor subunit 1 in monkey hippocampus. Proc Natl Acad Sci USA 91:564-568.
86. Sullivan JM, Traynelis SF, Chen H-SV, Escobar W, Heinemann SF, Lipton SA (1994) Identification of two cysteine residues that are required for redox modulation of the NMDA subtype of glutamate receptor. Neuron 13:929-936.
87. Sumi Y, Dent MA, Owen DE, Seeley PJ, Morris RJ (1992) The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development 116:625-637.
88. Tapparelli C, Metternich R, Ehrhardt C, Cook NS (1993) Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. Trends Pharmacol Sci 14:366-376.
89. Tingley WG, Roche KW, Thompson AK, Huganir RL (1993) Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain. Nature 364:70-73.
90. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT, Huganir RL (1997) Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site specific antibodies. J Biol Chem 272:5157-5166.
91. Traynelis SF, Cull-Candy SG (1990) Proton inhibition of N-methyl-D-aspartate receptors in cerebellar neurons. Nature 345:347-350.
92. Traynelis SF, Hartley M, Heinemann SF (1995) Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. Science 268:873-876.
93. Tsirka SE, Gualandris A, Amaral DG, Strickland S (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344.
94. Tsirka SE, Bugge TH, Degen JL, Strickland S (1997a) Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci USA 94:9779-9781.
95. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S (1997b) An extracellular protcolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552.
96. Umemori H, Inoue T, Kume S, Sekiyama N, Nagao M, Itoh H, Nakanishi S, Mikoshiba K, Yamamoto T (1997) Activation of the G protein Gq/11 through tyrosine phosphorylation of the a subunit. Science 276:1878-1881.
97. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
98. 2+ sensitivity of cloned NMDA receptors. Neuropharmacology 35:29-36.
99. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA (1998) Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228-231.
100. Wardlaw JM, Warlow CP, Counsell C (1997) Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 350:607-614.
101. Weinstein JR, Gold SJ, Cunningham DD, Gall CM (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15:2906-2919.
102. Whetsell WO (1996) Current concepts of excitotoxicity. J Neuropathol Exp Neurol 55:1-13.
103. Willmore LJ (1990) Post-traumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 31:[Suppl 3]:S67-S73.
104. Willmore LJ, Sypert GW, Munson JB, Hurd RW (1978) Chronic focal epileptiform discharge induced by injection of iron into rat and cat cortex. Science 200:1501-1503.
105. Xiong Z-G, Rauof R, Lu W-Y, Wang L-Y, Orser BA, Dudek EM, Browning MD, MacDonald JF (1998) Regulation of N-methyl-D-aspartate receptor function by constitutively active protein kinase C. Mol Pharmacol 54:1055-1063.
106. Yamada T, Nagai Y (1996) Immunohistochemical studies of human tissues with antibody to factor Xa. Histochem J 28:73-77.
107. Yamamoto K, Loskutoff DJ (1998) Extrahepatic expression and regulation of protein C in the mouse. Am J Pathol 153:547-555.
108. Yang Y, Akiyama H, Fenton JW, Brewer GJ (1997) Thrombin receptor on rat primary hippocampal neurons: coupled calcium and cAMP responses. Brain Res 761:11-18.
109. 2+ blockade of NMDA current in mechanically injured neurons. Science 274:1921-1923.
110. Zheng F, Gingrich MB, Traynelis SF, Conn PJ (1998) Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition. Nat Neurosci 1:185-191.
111. Zheng JQ, Wan JJ, Poo MM (1996) Essential role of filopodia in chemotropic turning of nerve growth cone induced by a glutamate gradient. J Neurosci 16:1140-1149.
112. 2+ influx amplifies protein kinase C potentiation of recombinant NMDA receptors. J Neurosci 15:8676-8686.
113. Zhuo M, Holtzman DM, Li Y, Osaka H, DeMaro J, Jacquin M, Bu G (2000) Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation. J Neurosci 20:542-549.